Arteris vs Ceva
Arteris is larger by market cap ($1.4B vs $870M). Ceva reports higher tracked revenue ($88M vs $71M). Both are primarily Semiconductor IP Licensing companies.
Shared segment: EDA & IP.
Side-by-side
| Arteris | Ceva | |
|---|---|---|
| Market cap | $1.4B | $870M |
| Revenue | $71M (FY2025) | $88M (FY2017) |
| Primary segment | Semiconductor IP Licensing | Semiconductor IP Licensing |
| Market position | niche | niche |
| Country | United States | Israel |
| Tracked suppliers | 0 | 0 |
| Tracked customers | 8 | 9 |
| Chokepoint / criticality | 50/100 | 50/100 |
Market caps/revenue from the wafergraph dataset · data as of 2026-08-12. Criticality is a graph-derived chokepoint score (0–100). Coverage is partial; "Unpriced" means no reliable market cap.
How Arteris and Ceva compare
- Size: Arteris is the larger company by market cap.
- Revenue: Ceva reports higher tracked revenue.
- Supply-chain criticality: Arteris has the higher chokepoint score (50/100 vs 50/100).
- Footprint: Arteris (United States) vs Ceva (Israel).